Although there is a paucity of animal studies on blood flow and its role in the maintenance of bone homeostasis and impairments in diabetes, it has been demonstrated that the anabolic effect of intermittent parathyroid hormone (PTH) therapy is associated with increased blood flow in bone, suggesting a supportive role of microvasculature during bone formation [33]. Here, PTH is linked to diabetes mellitus.